Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b, Multi-Center, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sildenafil Cream, 3.6% in Premenopausal Patients With Female Sexual Arousal Disorder (FSAD)

NCT04948151 is registered in ClinicalTrials.gov with Strategic Science & Technologies, LLC as lead sponsor.

NCT NCT04948151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04948151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b, Multi-Center, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sildenafil Cream, 3.6% in Premenopausal Patients With Female Sexual Arousal Disorder (FSAD)
Lead sponsor
Strategic Science & Technologies, LLC
Phase
Phase 2
Overall status
Unknown status
Start date
June 28, 2021
Completion date
December 15, 2021
Enrollment
440 (estimated)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

female sexual arousal disorder